These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 24623105

  • 21. Packaging of medicines for paediatric use: Prescrire's constructive proposals.
    Prescrire Int; 2012 Oct; 21(131):249-50. PubMed ID: 23185854
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Maximizing state and local medical countermeasure stockpile investments through the Shelf-Life Extension Program.
    Courtney B, Easton J, Inglesby TV, SooHoo C.
    Biosecur Bioterror; 2009 Mar; 7(1):101-7. PubMed ID: 19379109
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST, Pippins RR, Ngai JW.
    Food Drug Law J; 2009 Mar; 64(3):577-98. PubMed ID: 19999646
    [Abstract] [Full Text] [Related]

  • 28. Regulatory requirements for veterinary vaccine stability in the European Community.
    Fawthrop D.
    Dev Biol Stand; 1996 Mar; 87():319-27. PubMed ID: 8854032
    [Abstract] [Full Text] [Related]

  • 29. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L, Dabbah R, Hauck W, Sheinin E, Yeoman L, Williams R.
    AAPS J; 2005 Nov 17; 7(4):E786-812. PubMed ID: 16594632
    [Abstract] [Full Text] [Related]

  • 30. Risk evaluation mitigation strategies: the evolution of risk management policy.
    Hollingsworth K, Toscani M.
    Popul Health Manag; 2013 Apr 17; 16(2):132-7. PubMed ID: 23113627
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The FDA revises requirements for levothyroxine products.
    Burman K, Hennessey J, McDermott M, Wartofsky L, Emerson C.
    Thyroid; 2008 May 17; 18(5):487-90. PubMed ID: 18466074
    [No Abstract] [Full Text] [Related]

  • 33. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM, Tolomeo D, Gluck E.
    Food Drug Law J; 2009 May 17; 64(1):149-69. PubMed ID: 19998744
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Improving drug quality through certification experience.
    Weiss PJ.
    Am J Pharm Sci Support Public Health; 1974 May 17; 146(3):86-90. PubMed ID: 4852375
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Packaging and labeling of pharmaceutical products obtained from the internet.
    Veronin M.
    J Med Internet Res; 2011 Feb 15; 13(1):e22. PubMed ID: 21324833
    [Abstract] [Full Text] [Related]

  • 38. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep 29; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract] [Full Text] [Related]

  • 39. Two-phase shelf-life estimation.
    Shao J, Chow SC.
    Stat Med; 2001 Apr 30; 20(8):1239-48. PubMed ID: 11304739
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.